Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SweetBio is a medical device and biotechnology company that specializes in bioengineering medical-grade Manuka honey into advanced wound care products. The company's core technology utilizes a unique combination of honey and collagen to create dissolvable pads designed to accelerate the healing of chronic and acute wounds, such as diabetic ulcers and surgical sites. By leveraging the natural antibacterial and regenerative properties of honey through a sophisticated bioengineering process, SweetBio provides accessible and effective solutions for complex wound management. Headquartered in Memphis, Tennessee, the company is focused on expanding its product line and increasing accessibility to its innovative healing therapies across clinical and over-the-counter markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sweet.